Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT SureCall 2.1:
Breaking Barriers in
Clinical Research Sequencing
Maria Celeste M. Ramirez, Ph.D.
Global Product Manager, NGS
Michael Borns
R&D Scientist, Agilent
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
Addressing bottlenecks to ENABLE clinical research
What is SureSelectQXT?
50ng sample input
Fast turn-around time:
Streamlined workflow
Scalability
Sensitivity and Accuracy
The FASTEST capture solution in the market
For Research Use Only.
Not for use in diagnostic procedures
Addressing bottlenecks to ENABLE clinical research
What is SureSelectQXT?
50ng sample input
Fast turn-around time: 90 minute hyb, 3.5x faster than competition
Streamlined workflow Covaris-free, 30% less hands-on-time
Scalability
Sensitivity and Accuracy
The FASTEST capture solution in the market
For Research Use Only.
Not for use in diagnostic procedures
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
The Leader in Target Enrichment, now FASTER
COMPLETE and FLEXIBLE Solution
Superior PERFORMANCE
FASTEST Workflow
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
The Leader in Target Enrichment, now FASTER
COMPLETE and FLEXIBLE Solution
FASTEST Workflow
Superior PERFORMANCE
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT Sample to data in as little as 24 to 36 hours
*MiSeq, HiSeq systems
< 7 hours ~12.5*-27** hours
DATA in
24-36 hrs Transposase-
based
Library Prep
90-minute Hybridization
Sequence *MiSeq and **HiSeq
systems
• FAST, EASY and CONVENIENT:
30 min hands-on time for library prep
3.5h overall hands-on time
No special equipment required for fragmentation
• 50ng SAMPLE INPUT
NO MECHANICAL SHEARING
For Research Use Only.
Not for use in diagnostic procedures
Library Prep workflow
SPRI purification = 20min
200ng input
For Research Use Only.
Not for use in diagnostic procedures
Fragmentation PCR
~ 1.5 hours
SPRI purification = 20min
Hybridization Capture PCR
~ 5.5 hours
Library
QC
Library prep SureSelectQXT Target Enrichment
Library
QC
50 ng gDNA input
1.5 hours library prep workflow
90-minute hyb
SureSelectQXT Target Enrichment Workflow
For Research Use Only.
Not for use in diagnostic procedures
Library Prep Enrichment Sequence
SureSelectQXT The Fastest Enrichment Workflow
1 2 3 4 5
Competitor I
Competitor N
WORK DAYS
Agilent
SureSelectQXT
• ~4 day worfklow, 72h hyb
• 1ug input
• 1.5 day workflow, 5 hrs hands-on time: 2x capture and wash
• 50ng input
• Same day workflow, 90-min hyb, 3.5 hrs hands-on time
• 50ng input
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
The Leader in Target Enrichment, now FASTER
COMPLETE and FLEXIBLE Solution
Superior
PERFORMANCE
FASTEST Workflow
For Research Use Only.
Not for use in diagnostic procedures
SureSelect Target Enrichment: High-level performance enables accurate variant profiling
• high % mappable reads
• unparalleled % on-target
• deep and uniform coverage of ROIs
Mapping
Metrics
• high sensitivity enables accurate detection of SNVs,
InDels and CNVs
• excellent allelic balance
Variant
Calling
Metrics
For Research Use Only.
Not for use in diagnostic procedures
8 HapMaps
(ave)
V5 exome,
4Gb
Competitor I,
4Gb
Higher coverage of targets for the same amount of sequencing
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
Competitor I
60
65
70
75
80
85
90
95
100
bases at 1x coverage bases at 20x coverage % on target (+/- 100bp)
High performance from an accelerated workflow
Pe
rce
nta
ge
(%
) Mapping
Metrics
Variant
Calling
Metrics
Comprehensive Variant Detection
More SNPs and Indels identified
• Longer baits: tolerate larger regions of mismatch
• RNA baits: stronger interaction with DNA targets
NA18507
V5 exome, 4Gb
Competitor I, 4Gb
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT + V5 Competitor I
SNPs
evaluated sites 52174 33823
sites that overlap with
dbSNP 50779 (97%) 32205 (95%)
concordant SNPs 50705 (100%) 32163 (99.8%)
novel SNPs 1395 1618
InDels
evaluated sites 3756 1738
sites that overlap with
dbSNP 3295 (88%) 1481 (85%)
concordant SNPs 3120 (95%) 1381 (93%)
novel SNPs 461 257
SureSelectQXT
The Leader in Target Enrichment, now FASTER
COMPLETE and FLEXIBLE Solution
FASTEST Workflow
Superior PERFORMANCE
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
SureSelectQXT - Not Just for Exomes Custom capability through SureDesign
CUSTOM
For Research Use Only.
Not for use in diagnostic procedures
SureCall
SureSelectQXT Faster sample to data with SureCall
For SureSelect
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
• Whole genome sequencing
(library prep only)
• Small or large genomes
Library Prep
Target Enrichment
Standalone Barcodes
SureSelectQXT Complete and flexible solution for WGS and target enrichment
• Targeted resequencing
(library prep + enrichment)
• Catalog (exomes, kinome)
• Custom (up to 24Mb)
For Research Use Only.
Not for use in diagnostic procedures
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
21
PCR-ready template
Fragmentation and
Tag Addition
Gap Repair Template DNA
For Research Use Only.
Not for use in diagnostic procedures
Library Prep
Baits + Hyb and
Wash Buffers
Target Enrichment
Library
Prep
Whole
Genome
Sequencing
SureSelectQXT Complete and flexible solution for WGS and target enrichment
For Research Use Only.
Not for use in diagnostic procedures
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
24
Reference: Poster #P045 presented at Plant and Animal Genome Asia 2014 (Singapore)
Notes: - 50ng bacterial gDNA was used for each experiment.
- Sequencing reads were normalized to half the size of each bacterial genome for comparison purposes.
Whole genome sequencing using SureSelectQXT
and bacterial genomes of varying GC content:
For Research Use Only.
Not for use in diagnostic procedures
25
Reference: Poster #P045 presented at Plant and Animal Genome Asia 2014 (Singapore)
SureSelectQXT versus competitor kit C.jejuni DNA (30% GC)
For Research Use Only.
Not for use in diagnostic procedures
26
Notes: - 50ng human gDNA (HapMap NA10831) was used for each experiment.
- Sequencing reads were normalized 600 million (2X100) for comparison purposes.
Whole genome sequencing using human gDNA
% duplication
SureSelectXT 2.74
SureSelectQXT 4.21
Competitor I 4.37
For Research Use Only.
Not for use in diagnostic procedures
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 5 10 15 20 25 30 35 40
Competitor I
SureSelectXT
SureSelectQXT
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
28
For Research Use Only.
Not for use in diagnostic procedures
29
Optimal Transposase Fragmentation Profile
Notes: - 50ng human gDNA input, NA12878
- 45°C, 10 minute incubation
- Post-PCR
For Research Use Only.
Not for use in diagnostic procedures
High Performing Exome Captures with SureSelectQXT
0
10
20
30
40
50
60
70
80
90
100
NA 18507 NA 18997 NA 12878 NA 12155 NA 12891 NA 12156 NA 18953 NA 10831
Percent duplicate reads:
Percentage reads in targeted regions:
Percentage reads in targeted regions +/- 100bp:
...at least 1 read:
...at least 5 reads:
...at least 10 reads:
...at least 20 reads:
Average Std. Dev. %CV High Low
Percent duplicate reads: 9.51 0.475 4.99 10.26 8.74
Percentage reads in targeted regions: 71.35 1.474 2.07 74.01 68.43
Percentage reads in targeted regions +/- 100bp: 88.44 1.532 1.73 90.58 85.43
Percentage of targeted bases covered by…
...at least 1 read: 98.97 0.058 0.06 99.06 98.86
...at least 5 reads: 96.72 0.158 0.16 97.04 96.51
...at least 10 reads: 92.52 0.325 0.35 93.02 92.04
...at least 20 reads: 81.95 0.547 0.67 82.92 81.08
8 HapMaps in duplicate
V5 exome, 4Gb
2x100bp
For Research Use Only.
Not for use in diagnostic procedures
31
0
20
40
60
80
100
120
bases at 1x coverage bases at 20x coverage % on target (+/- 100bp)
8 HapMaps
(ave)
V5 exome,
4Gb
Competitor I,
4Gb
Pe
rce
nta
ge
(%
)
SureSelectQXT
SureSelectXT
High Performing Exome Captures with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
8 HapMaps
(ave)
V5 exome,
4Gb
Competitor I,
4Gb
Higher coverage of targets for the same amount of sequencing
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
Competitor I
60
65
70
75
80
85
90
95
100
bases at 1x coverage bases at 20x coverage % on target (+/- 100bp)
High performance from an accelerated workflow
Pe
rce
nta
ge
(%
)
Confidence in variant calling with SureSelectQXT
Hom/Het for HapMap
Hapmap NA18507 NA18997 NA12878 NA12155 NA12891 NA12156 NA18953 NA10831
CONCORDANCE
GT is REF 99.96% 99.95% 99.97% 99.97% 99.98% 99.96% 99.97% 99.97%
GT is variant HOM 98.97% 99.06% 98.94% 98.95% 98.89% 98.86% 99.02% 98.96%
GT is variant HET 99.49% 99.44% 99.51% 99.71% 99.37% 98.48% 99.60% 99.56%
SENSITIVITY
GT is REF 99.95% 99.92% 99.92% 99.93% 99.89% 99.93% 99.89% 99.91%
GT is variant HOM 99.77% 99.79% 99.78% 99.75% 99.61% 99.73% 99.79% 99.68%
GT is variant HET 99.36% 99.37% 99.29% 99.36% 98.61% 98.88% 99.10% 99.54%
Hom/Het for dbSNP
Hapmap NA18507 NA18997 NA12878 NA12155 NA12891 NA12156 NA18953 NA10831
n_eval_sites 52174 42880 42871 42724 41458 42482 42090 42418
concordance_rate 99.86% 99.87% 99.88% 99.87% 99.90% 99.91% 99.86% 99.91%
Indels for dbSNP
Hapmap NA18507 NA18997 NA12878 NA12155 NA12891 NA12156 NA18953 NA10831
n_eval_sites 3756 3184 3234 3162 2966 3046 3001 3056
concordance_rate 94.69% 95.66% 95.74% 94.92% 96.14% 96.36% 95.59% 95.93%
Notes: - Average of 2 replicate libraries for each hapmap.
- All libraries were normalized to 40 million reads (2X100).
8 HapMaps
V5 exome,
4Gb For Research Use Only.
Not for use in diagnostic procedures
V5 exome data, 4Gb
8 HapMaps
High sensitivity and concordance
SureSelectQXT
SureSelectQXT
SureSelectXT
For Research Use Only.
Not for use in diagnostic procedures
Comprehensive and balanced variant detection
More SNPs and Indels identified
• Longer baits: tolerate larger regions of mismatch
• RNA baits: stronger interaction with DNA targets
V5 exome, 4Gb
Competitor I, 4Gb
For Research Use Only.
Not for use in diagnostic procedures
SureSelectQXT
Competitor I
SureSelectQXT + V5 Competitor I
SNPs
evaluated sites 52174 33823
sites that overlap with
dbSNP 50779 (97%) 32205 (95%)
concordant SNPs 50705 (100%) 32163 (99.8%)
novel SNPs 1395 1618
InDels
evaluated sites 3756 1738
sites that overlap with
dbSNP 3295 (88%) 1481 (85%)
concordant SNPs 3120 (95%) 1381 (93%)
novel SNPs 461 257
*NA18507
Excellent Reproducibility with SureSelectQXT
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
-1 4 9 14 19 24
Percent duplicate reads:
Percentage reads in targeted regions:
Percentage reads in targeted regions +/- 100bp:
...at least 1 read:
...at least 10 reads:
...at least 20 reads:
Average Std. Dev. %CV High Low
Percent duplicate reads: 8.75 0.721 8.24 10.04 6.15
Percentage reads in targeted regions: 64.00 2.618 4.09 68.98 50.66
Percentage reads in targeted regions +/- 100bp: 79.67 4.228 5.31 86.69 62.05
Percentage of targeted bases covered by…
...at least 1 read: 98.66 0.030 0.03 98.73 98.48
...at least 10 reads: 95.47 0.296 0.31 96.04 94.4
...at least 20 reads: 88.3 0.971 1.1 90.04 84.03
24 samples
Kinome, 300Mb
2x100bp
For Research Use Only.
Not for use in diagnostic procedures
Ave of 72 samples (24 samples x 3 users)
Kinome, 300Mb, 2x100bp
High performance from large or small captures
0
10
20
30
40
50
60
70
80
90
100
rep-1 rep-2 rep-3 rep-4 rep-5 rep-6
Percent duplicate reads:
Percentage reads in targeted regions:
Percentage reads in targeted regions +/- 100bp:
...at least 1 read:
...at least 5 reads:
...at least 10 reads:
...at least 20 reads:
8 Hapmaps
1Mb, 100Mb
2x100bp
Average Std. Dev. %CV High Low
Percent duplicate reads: 8.64 0.607 7.03 9.37 7.64
Percentage reads in targeted regions: 76.19 1.715 2.25 78.77 75.33
Percentage reads in targeted regions +/- 100bp: 84.52 1.895 2.24 87.32 81.66
Percentage of targeted bases covered by…
...at least 1 read: 99.58 0.048 0.05 99.62 99.49
...at least 10 reads: 97.55 0.209 0.21 97.79 97.19
...at least 20 reads: 93.44 0.749 0.80 94.07 92.04
Notes: - Average of 6 replicate libraries.
- All libraries were normalized to 1 million reads (2X100).
For Research Use Only.
Not for use in diagnostic procedures
Kinome Rep-1 Rep-2 Rep-3
% dups 6.05 6.09 6.73
% on target 62.86 62.17 64.09
Percentage of
targeted bases
covered by
1x 98.91 98.97 98.92
10x 96.79 96.46 96.25
20x 93.06 92.19 91.70
Kinome Rep-1 Rep-2 Rep-3
% dups 8.93 8.99 9.74
% on target 67.20 67.34 71.79
Percentage of
targeted bases
covered by
1x 98.69 98.66 98.69
10x 96.12 96.08 96.31
20x 91.55 91.31 92.27
Kinome Rep-1 Rep-2 Rep-3
% dups 7.19 7.52 7.32
% on target 65.34 66.60 66.63
Percentage of
targeted bases
covered by
1x 98.85 98.82 98.84
10x 96.52 96.53 96.67
20x 92.76 92.76 93.20
Under fragmentation
Optimal fragmentation
Over fragmentation
Variable DNA fragmentation profiles and their
effect on target-enriched sequencing results
Kinome,
300Mb
2x100bp For Research Use Only.
Not for use in diagnostic procedures
AGENDA
Introducing SureSelectQXT
Benefits of SureSelectQXT
1
2
The SureSelectQXT Transposase
3
4 SureSelectQXT for Whole Genome Sequencing
5
SureCall 2.0: Faster time to results 6
Accelerated Target Enrichment with SureSelectQXT
For Research Use Only.
Not for use in diagnostic procedures
The Analysis Pipeline Puzzle: Piecing together different solutions for different steps
41
For Research Use Only.
Not for use in diagnostic procedures
Control
Software
FASTQ
file
reads +
quality
1. Primary Analysis
Aligner
BAM file
reads
aligned to
genome
FASTQ
file
reads +
quality
2. Read Alignment
Variant
caller
VCF file
variant
call
format
BAM file
reads
aligned to
genome
3. Variant Calling
Additional filtering on read depth & quality score
Filter based on population frequencies
Non-synonymous variants
Functional prediction
Inheritance pattern
Final
report
VCF file
variant
call
format
Mutation
report
3. Tertiary analysis: interpretation
SureCall: from alignment to mutation report
42
For Research Use Only.
Not for use in diagnostic procedures
Guided data analysis from alignment to categorization of mutations
• Streamlined Workflow
• Faster Time to Results
- Alignment of FASTQs to variants
• Designed for clinical research
• Free of Charge
www.agilent.com/genomics/surecall
SureCall 2.0: Simplified Raw Data to Variants
Page 43
For Research Use Only.
Not for use in diagnostic procedures
SureCall’s Simple 3-Step Analysis Workflow
1. Import Sample FASTQs
2. Describe Samples
3. Run Analysis
44
For Research Use Only.
Not for use in diagnostic procedures
Types of Analysis
Description Result
Single Sample Analysis • For individual samples • SNPs and indels
Pair Analysis • CNV analysis using normal reference
• Paired tumor-normal samples
• SNPs and indels
• CNVs
• Somatic mutations
Trio Analysis • For trios, typically mother, father and child • SNPs and indels
• De novo mutations
45
SureSelectQXT
Trimmer Yes
Remove Duplicates Yes
Region Padding Yes - 100 bp
For Research Use Only.
Not for use in diagnostic procedures
Visualize and review categorized mutations from the entire capture…
For Research Use Only.
Not for use in diagnostic procedures
New in SureCall 2.1: Analyze the entire capture, focus on your known variants
For Research Use Only.
Not for use in diagnostic procedures
Visualize and review only your known variants
For Research Use Only.
Not for use in diagnostic procedures
49
Definitive Answers, FASTER
• SNPs and Indels
For Research Use Only.
Not for use in diagnostic procedures
• Copy number variants
Enabling a Clinical Research Workflow
SEQUENCE
<1.5 day
3
DESIGN
~10 mins
1 4
ANALYZE
~1 hour
ENRICH
<1 day
2
For Research Use Only.
Not for use in diagnostic procedures
Thank You!
SureSelectQXT
Introductory Promotion
50% discount when purchased with an
exome or a qualifying custom bait library
Contact your local rep for more information